7 Green Days In A Row: Clorox Stock Is Up 21%
Shares of Clorox (CLX) have closed higher in each of the last 7 sessions, a cumulative gain of 21.1%. That added about $2.3 billion to the company’s market value, which now stands at about $13.0 billion. The stock closed at $106.60 on Tuesday, November 10, 12.9% below its 52-week high of $122.35 and 34.5% above its low of $79.26.
How The Streak Stacks Up Against The S&P 500
Returns for CLX and the S&P 500 over the streak and the periods around it, all ending Tuesday, November 10 and including dividends:
| Return Period | CLX | S&P 500 |
|---|---|---|
| 1 Day | 1.0% | -0.4% |
| 7 Days (Current Streak) | 21.1% | -0.8% |
| 1 Month (21 Trading Days) | 28.2% | -3.6% |
| 3 Months (63 Trading Days) | 2.3% | -2.7% |
| Year To Date | 11.1% | 10.9% |
| 1 Year (252 Trading Days) | 4.3% | 13.1% |
A Stock-Specific Run, Or A Market Move?
The market explains little of this: the S&P 500 lost 0.8% over the same 7 sessions, including dividends, against Clorox’s +21.1%. No other S&P 500 stock is currently on a winning streak of 7 days or longer. Over the past three months the stock is up 2.3%, a window that includes the streak; over the other 56 sessions of that window it was down 15.6%.
What The Numbers Say About The Rally
On the fundamentals, revenue grew 6.3% over the last twelve months, against a median of 5.4% for S&P 500 Consumer Staples stocks; its operating margin is 14.1%, versus a median of 14.9%; and the stock trades at 19.2 times trailing earnings against a median of 22.6. The read is mixed: revenue growth above the median and a multiple below the median on one side, margins below the median on the other.
A climb like this is worth respecting, and worth testing. Our Guidance Momentum screen tracks the stocks whose companies just raised their own forward numbers.
One Hot Stock Is A Story. Thirty Sound Ones Are A Strategy
A streak like this earns a place on your watchlist, and it also earns a question: how much of your outcome do you want depending on one company keeping this up?
The Trefis High Quality (HQ) Portfolio answers it with breadth: roughly 30 businesses picked for consistent cash generation, strong margins, and balance-sheet strength, sized and rebalanced by rules. It has a track record of outpacing a benchmark that combines the S&P 500, the S&P MidCap 400, and the Russell 2000. Follow the story; invest in the strategy.